Healthcare Services

Huntington’s Disease Market: Opportunities and Growth Outlook

April 22, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Huntington’s Disease Market Grow Between 2026 And 2030?

The huntington’s disease market has experienced rapid expansion in recent years. Projections indicate it will grow from $0.55 billion in 2025 to $0.64 billion in 2026, at a compound annual growth rate (CAGR) of 17.9%. The market’s historic growth is attributable to factors such as the identification of the htt gene mutation, the limited availability of curative treatments, increased awareness of rare neurodegenerative diseases, a reliance on symptomatic therapies, and the rising diagnosis rates through genetic testing.

The market for Huntington’s disease is projected to experience substantial expansion over the coming years, reaching a valuation of $1.22 billion by 2030, at a compound annual growth rate (CAGR) of 17.5%. This projected growth is primarily due to several factors, including breakthroughs in gene therapy and RNA-based treatments, increased funding for rare disease research, a growing number of clinical trials for disease-modifying therapies, a heightened emphasis on early intervention approaches, and enhanced backing from patient advocacy groups. Key trends anticipated during this period involve a stronger focus on disease-modifying and gene silencing treatments, greater uptake of genetic testing for prompt and precise diagnosis, an increasing emphasis on comprehensive, multidisciplinary strategies for symptom management, the expansion of clinical trials aimed at neurodegenerative conditions, and the growth of patient-centered care models, including home-based management options.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/huntingtons-disease-global-market-report

What Key Drivers Are Fueling The Growth Of The Huntington’s Disease Market?

The increasing occurrence of neurological disorders is anticipated to stimulate the expansion of the huntington’s disease market in the foreseeable future. Neurological disorders are health conditions affecting the brain, spinal cord, and nerves, resulting in symptoms such as issues with movement, coordination, sensation, or cognitive abilities. The rise in these disorders can be attributed to factors like aging populations, environmental toxins, lifestyle changes, improved diagnostic capabilities, and genetic predispositions, which facilitate the identification of more cases. Huntington’s disease is a specific neurodegenerative disorder stemming from a genetic mutation, leading to motor dysfunction, cognitive decline, and psychiatric symptoms that worsen progressively. For instance, in March 2023, the Alzheimer’s Association, a US-based nonprofit voluntary health organization, stated that an estimated 6.7 million Americans aged 65 and older currently have Alzheimer’s dementia. Without medical breakthroughs to prevent, slow, or cure the disease, this number could rise to 13.8 million by 2060. Thus, the increasing prevalence of neurological disorders is propelling the growth of the huntington’s disease market.

How Are Different Segments Classified In The Huntington’s Disease Market Segment Analysis?

The huntington’s disease market covered in this report is segmented –

1) By Treatment Type: Symptomatic Therapy, Disease-Modifying Therapy, Other Treatment Types

2) By Diagnosis: Magnetic Resonance Imaging (MRI), Genetic Testing

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Symptomatic Therapy: Antipsychotics, Antidepressants, Mood Stabilizers, Muscle Relaxants

2) By Disease-Modifying Therapy: Gene Silencing Therapies, Neuroprotective Agents

3) By Other Treatment Types: Physical Therapy, Occupational Therapy, Speech Therapy

What Trends Are Influencing The Huntington’s Disease Market?

Leading companies active in the Huntington’s disease market are concentrating on creating innovative treatments, such as oral small molecule drugs, to manage symptoms and delay disease progression. An oral small molecule drug is characterized as a low-molecular-weight compound that can be taken by mouth and is formulated to interact with biological targets, including proteins or enzymes, for disease treatment. For example, in September 2024, PTC Therapeutics Inc., a US-based pharmaceutical company, obtained Fast Track designation from the U.S. Food and Drug Administration (USFDA) for its PTC518 program, which is designed to treat Huntington’s disease. This designation is given to therapies addressing significant unmet medical needs, emphasizing PTC518’s potential as a disease-modifying treatment for patients affected by this genetic disorder.

Who Are The Companies Driving Activity In The Huntington’s Disease Market?

Major companies operating in the huntington’s disease market are Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc, Ipsen S.A., Vertex Pharmaceuticals Incorporated, H. Lundbeck A/S, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited., Neurocrine Biosciences Inc., Alnylam Pharmaceuticals Inc, PTC Therapeutics Inc., Annexon Inc., Voyager Therapeutics Inc., Stealth BioTherapeutics Corp., Vaccinex Inc., SOM Biotech S.L., Alterity Therapeutics Limited, Medesis pharma SA.

Get The Full Huntington’s Disease Market Report:

https://www.thebusinessresearchcompany.com/report/huntingtons-disease-global-market-report

Which Region Accounts For The Largest Portion Of The Huntington’s Disease Market?

North America was the largest region in the huntington’s disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the huntington’s disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Huntington’s Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/huntingtons-disease-global-market-report

Browse Through More Reports Similar to the Global Huntington’s Disease Market 2026, By The Business Research Company

Alzheimers Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Rare Neurological Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-neurological-disease-treatment-global-market-report

Progressive Ataxia And Weakness Disorders Market Report 2026

https://www.thebusinessresearchcompany.com/report/progressive-ataxia-and-weakness-disorders-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795